JENA, Germany, May 9, 2014 — Demand for intraocular lenses and microsurgery products boosted business for medical technology company Carl Zeiss Meditec AG in the first six months of its fiscal year. Revenue increased by around 4 percent year-on-year, to €461 million. “Overall, we are satisfied with this performance,” said President and CEO Dr. Ludwin Monz. “We are particularly encouraged by the double-digit organic growth of our Surgical Ophthalmology business unit." The company’s microsurgery unit saw revenues increase 0.3 percent over the first half of last year to €207.3 million; refractive lasers for the correction of myopia drove growth of 2.5 percent to €180.2 million in the ophthalmic systems unit; and surgical ophthalmology grew by 21.5 percent to €73.4 million. The Europe, Middle East and Africa regions grew by 3.8 percent, to €158.5 million compared to €152.6 million last year, while unfavorable currency conversion rates hampered business in the Asia-Pacific and Americas regions. The Americas business declined by 1.5 percent; adjusted for currency effects, the region would have reported growth of 1.9 percent. Revenue from Asia grew 9.8 percent to €160.8 million.